ARIAD Pharmaceuticals Inc

In July 2017, the FDA accepted Bristol-Myers Squibb’s supplemental New Drug Application (or sNDA) for expanding the indication of Sprycel.

As we’ve discussed, Novartis (NVS) is one of the largest pharmaceutical companies by revenue.